Body composition was determined using dual-energy X-ray absorptiometry (DXA) in a subset of patients without (BLOSSOM) and with (BLOOM-DM) type 2 diabetes who received diet and exercise counselling along with either lorcaserin 10 mg twice daily or placebo. DXA scans were performed on study day 1 (baseline), week 24 and week 52. Baseline demographics of the subpopulations (without diabetes, n = 189; with diabetes, n = 63) were similar between studies and representative of their study populations. At week 52, patients without diabetes on lorcaserin lost significantly more fat mass relative to those on placebo (−12.06% vs −5.93%; p = 0.008). In patients with diabetes, fat mass was also decreased with lorcaserin relative to placebo (−9.87% vs −1.65%; p
Crooks at it again this week!
Someone is scooping up the available in exercised shares.
Is this how you read it?
JMHO but they know bigger news still to come. Hence the fake options that magically disappear every week.
Like clock work..
Go figure it's Wall Street!
What Analysts Say about this Stock:
The Company has received rating from WSJ analysts. Currently the stock has been rated as “Buy” from 2 Analysts. 0 analysts have suggested “Sell” for the company. 5 analysts have rated the company as a “Hold”. Overweight rating was given by 0 analysts and Underweight rating was given by 0 analysts. The stock has received “Overweight” rating after consensus analysis from analysts.
Mortimer buy, buy, buy!!!!!!!!D@mn you.
That's the only way you're going to get ARNA shares :)
Can not wait to file my lawsuit against the naked shorts!!!!!!!!!
Additionally, shorts won't mention the $7.2 Billion valuation given to Receptos. ARNA should be at that valuation or more! JMHO
I know will be extremely successful; 68 Million short to 16 Million Short and the price goes down all the while institutional ownership increases! GTFOH
The Supreme has opened the flood gates😀
I think I know the answer.......
I think Karl is betting on it!
Yahoo won't let me post.......